Development of a New Rapid Diagnostic Test to Support Onchocerciasis Elimination

Key facts

Sponsor

Bioaster

Principal Investigator

Philippe LEISSNER

Bioaster

Intervention

Biological samples collection (blood drawing + feces)(biological)

Enrollment

400 enrolled

Eligibility

18 years · All sexes

Timeline

2024 – 2025

Study locations (1)

• Higher Institute for Scientific and Medical Research, Yaoundé, Cameroon

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Other trials for Onchocerciasis

Additional recruiting or active studies for the same condition.

• ACTIVE NOT RECRUITINGPHASE2NCT05180461
  Emodepside Phase II Trial for Treatment of Onchocerciasis
  Drugs for Neglected Diseases
• ACTIVE NOT RECRUITINGPHASE3NCT03876262
  Safety and Efficacy of Annual or Biannual Doses of Moxidectin or Ivermectin for Onchocerciasis
  Medicines Development for Global Health

See all trials for Onchocerciasis →